A growing number of trials and studies are showing the superior absorption levels of transdermal magnesium compared to tablet and capsule supplementation.
Absorption research is fundamental to BetterYou as a brand and as such it has seen us work with some of the world’s leading institutions and associations, adding to the wealth of trials available.
Key finding: The skin started absorption with immediate effect
This in-vitro clinical trial carried out by the University of Cardiff proved that elemental magnesium could be delivered to the cells of the body through a transdermal delivery (through the skin). The trial showed that the skin started absorption with immediate effect and the action was accelerated with a short period of massaging the application area after spraying. It also pointed out that certain additional ingredients (such as aloe vera) can block the magnesium absorption if used together while others (menthol or wintergreen) can enhance absorption.
In vitro transdermal delivery of magnesium – Dr Heard and Dr Houston – Cardiff University Pharmacy and Pharmacology Department 2010.
Request a copy >
Key finding: Magnesium uptake 5 times faster than tablets
In this study both the blood level as well as the cellular magnesium content were determined with the help of a hair analysis before and after a twelve week transdermal application with a 31 percent saturated magnesium chloride solution. Thereby after a twelve week course of treatment an average rise in the cellular magnesium content of 59.5 percent was determined in 89 percent of the test subjects. With oral magnesium intake, comparable results could first be achieved after nine to twenty four months. Furthermore, all patients showed an average improvement of 25.2 percent in the calcium-magnesium ratio during the test period. As a side effect, clear indications of a detoxification of heavy metals was observed in 78 percent of the test subjects.
A pilot study to determine the impact of transdermal magnesium treatment on serum levels and whole body CaMg ratios – Watkins, K & Josling, PD – The Nutrition Practitioner, Spring 2010
Key finding: Magnesium reduces severity and frequency of attacks
A 3-month trial undertaken by Migraine Action, involving 68 participants who experienced at least three migraines each month. Each migraine sufferer used BetterYou™ MagnesiumOil Original spray twice daily (10-20 sprays in all), whilst keeping a migraine diary to track progress. Overall, 50% of the subjects experienced a positive effect on their migraines. All of these sufferers experienced a decrease in the overall severity of attacks and three quarters of them experiencing a reduction in the duration of attacks.
Read the thoughts of one of the trials participants >
Key finding: Significant benefit for fibromyalgia sufferers
The renowned Mayo Clinic in Rochester (USA) investigated, whether magnesium applied transdermally in the form of MagnesiumOil works for fibromyalgia. 40 women with the clinically determined diagnosis “Fibromyalgia” took part in the study. With the help of a special fibromyalgia questionnaire, the type and manifestation of the complaints were documented on a scale. The data were recorded at the beginning, after 2 weeks and 4 weeks treatment time. Every participant was asked to spray and massage in 4 spray strokes twice a day on the arms and legs for 4 weeks. 24 participants completed the study. For all participants, all complaints improved significantly.
Effects of transdermal magnesium chloride on quality of life for patients with fibromyalgia: a feasibility study – Engen D.J, McAllister S.J., Whipple M.O., Cha S.S., Dion L-J., Vincent A., Bauer B.A., Wahner-Roedler D.L. – Journal of Integrative Medicine Editorial Office.